Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Short SellingSee which listed companies have disclosed short interest
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Log in to your Inderes Free account to see all free content on this page.
Create account

Physitrack

11.10 SEK-1.33 %13.11. klo 18.29
Less than 1K followers

PTRK

First North Stockholm

Software

Technology

Overview
Financials & Estimates
Ownership
Dividend
Short Selling
Investor views
Compare
-1.33 %
-0.45 %
+27.29 %
+39.80 %
-15.27 %
-24.49 %
-37.64 %
-77.76 %
-76.13 %

Physitrack operates in the healthcare sector and specializes in physiotherapy. The product portfolio includes digital healthcare offerings for companies via SaaS solutions. In addition to the main business, personal service and related ancillary services are also offered. The business is operated globally with the largest presence in Europe and North America. Physitrack was founded in 2012 and is headquartered in London.

Read more
Market cap
180.49M SEK
Turnover
58.59K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
EPS and dividend
Financial calendar
All
Webcasts
Press releases
3rd party
ShowingAll content types

Forum discussions
The EMR and the overall package are starting to show really huge growth potential. The rollout is now underway across all English-speaking operating countries. 700 clinics and nearly 7,000 practitioners are currently on the trial period. More will be joining over the next couple ...
11/3/2026, 9:38 AM
by kettunen
3
Q3 came out this week; sharing my comments with a slight delay due to being busy at work, as there don’t seem to be any other active posters around here Good growth, and it’s now also trickling down to the bottom line since the non-recurring expenses have been dealt with and lower...
10/25/2026, 4:54 PM
by kettunen
3
This shouldn’t really come as a surprise anymore, so the EMR has been launched. Physitrack Launches Next-Generation EMR, Powered by Agentic AI Physitrack plc (Nasdaq First North: PTRK) launches AI agentic EMR that turns the consultation itself into the clinical record, moving the...
9/28/2026, 8:18 AM
by kettunen
3
Turns out this isn’t such a small market after all LinkedIn #physitrack #physiotimes #physiotherapy #emr | Physitrack Less time on admin, more time for patient care. 💚 We’re excited to collaborate with PHYSIOTIMES to introduce Physitrack EMR to physiotherapists across India. Thank...
10/27/2026, 12:10 PM
by kettunen
2
Opening up the US market, quite a decent-sized contract compared to Physitrack’s previous ones and a testament to the system’s capability. MFN – 7 Sep 26 Physitrack PLC: Physitrack Wins Deal with Large US Healthcare Syste... Three-year enterprise agreement with a total contract value...
9/7/2026, 9:35 AM
by kettunen
2
Q2 out storage.mfn.se q2-2026-interim-report-english.pdf Reasonable growth percentages, though moderate in absolute terms. Cash flow positive in Q2, which is a good situation for a cost-heavy quarter. The RTM product in the US market has started generating revenue; this likely holds...
7/21/2026, 6:37 AM
by kettunen
2
Let’s keep going, the number of sign-ups for the trial period is growing quite well 1,000 clinicians in 9 days – there is definitely demand and interest More about the EMR over there. At first glance, it really looks like quite a capable tool Physitrack Physical Therapy EMR / PMS...
10/7/2026, 12:28 PM
by kettunen
1
Read more on our forum
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
26.2.
2027

Annual report '26

Press release09.11.2026 klo 10.30

Physitrack Selected by the Largest Private Physiotherapy Chain in the Netherlands

Physitrack
Regulatory press release09.11.2026 klo 09.30

Physitrack PLC — Transactions under Share Buy-back Programme

Physitrack
Press release02.11.2026 klo 10.30

Physitrack Releases its Agentic AI EMR to Clinics Worldwide, Rated #3 EMR by G2

Physitrack

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and deep analyses
Premium tools: model portfolio, screener, insider transactions
Premium columns: Guest column, expert insights
Inderes MCP - Inderes data directly into your AI tools
Create account
Regulatory press release02.11.2026 klo 09.30

Physitrack PLC — Transactions under Share Buy-back Programme

Physitrack
Regulatory press release26.10.2026 klo 09.00

Physitrack PLC — Transactions under Share Buy-back Programme

Physitrack
Regulatory press release22.10.2026 klo 16.00

Physitrack PLC: Notification of Managers' Transactions

Physitrack
Press release21.10.2026 klo 14.00

Redeye: Physitrack (Q3 Review): Back to growth: transition from add-on to platform

Physitrack
Regulatory press release20.10.2026 klo 09.00

Physitrack Plc: Interim Report Q3 2026 – Growth Accelerating: Revenue Up 14 per cent, Two US Healthcare System Selections, EMR Launched, Company Profitable and Cash Generative

Physitrack
Regulatory press release20.10.2026 klo 09.00

Physitrack Plc: Delårsrapport Q3 2026 – Tillväxten accelererar: Intäkterna ökar 14 procent, två vårdsystem i USA väljer Physitrack och EMR lanseras, fortsatt lönsamhet och positivt kassaflöde

Physitrack
Press release19.10.2026 klo 10.00

Physitrack EMR early access reaches 480 clinic signups representing over 4,700 clinicians

Physitrack
Regulatory press release19.10.2026 klo 09.30

Physitrack PLC — Transactions under Share Buy-back Programme

Physitrack
Press release13.10.2026 klo 09.30

Invitation to Physitrack PLC Q3 2026 interim report webcast conference

Physitrack
Regulatory press release12.10.2026 klo 09.30

Physitrack PLC — Transactions under Share Buy-back Programme

Physitrack
Press release09.10.2026 klo 16.30

Physitrack EMR Waitlist Reaches 2,100 Practitioners as Commercial Rollout Accelerates

Physitrack
Press release05.10.2026 klo 11.00

Physitrack sets out commercial model for its EMR as more than 100 clinics sign up for early access in five days

Physitrack
Regulatory press release05.10.2026 klo 09.30

Physitrack PLC — Transactions under Share Buy-back Programme

Physitrack
Press release02.10.2026 klo 14.21

Redeye: Physitrack (Q3 Preview): Steady Growth, EMR in Focus

Physitrack
Press release28.09.2026 klo 13.57

Redeye: Physitrack: EMR launch marks shift from add-on to system of record

Physitrack
Regulatory press release28.09.2026 klo 12.30

Physitrack PLC — Transactions under Share Buy-back Programme

Physitrack
Press release28.09.2026 klo 09.30

Physitrack Launches Next-Generation EMR, Powered by Agentic AI

Physitrack